NKEA healthcare progress update

The Minister of Health, Malaysia announced five new projects, on 2nd August 2013, under the Healthcare National Key Economic Area (NKEA) with a total investment value of RM388.1mil and a projected gross national income of RM445.2mil.

These initiatives could potentially reduce reliance on imports of these healthcare products by manufacturing them locally instead through locally incorporated companies and multinational ones. “Currently Malaysia relies on imported infusion products which are costly. It is timely to have a manufacturing capability on our home ground,” he said in his speech.

Five locally incorporated companies will expand their investments through this initiative.

They are: (1) ABio Orthopaedics will invest RM224.5mil for the expansion of orthopaedic devices contract manufacturing in Penang, (2) Karl Mueller Scientific Sdn Bhd will invest RM1.4mil to produce single and disposable medical devices and accessories, (3) Kotra Pharma will invest RM60mil to produce sterile injectables or infusion products, (4) RB Lifescience Sdn Bhd investing RM94.5mil for the construction of a new pharmaceutical plant and (5) S-ima Medical to invest RM7.7mil for the development of orthopaedic clinical devices.

the STAR 02-08-2013

Post a Comment